Anest. intenziv. Med. 2025;36(4):247-252 | DOI: 10.36290/aim.2025.043

Comparison of ibuprofen and paracetamol combination with ketorolac and paracetamol in patients undergoing gynecologic surgery:  A review of pain level, coagulation profile, and interleukin-6 levelsOriginal Article

Maarif M. K.1, Musba A. M. T.1, 2, Datu M. D.1, 3, Gaus S.1, 2, Wirawan N. S.1, 3, Adil A.1, 2
1 Department of Anesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
2 Department of Anesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Dr. Wahidin Sudirohusodo General Hospital, Makassar, Indonesia
3 Department of Anesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Hasanuddin University Hospital, Makassar, Indonesia

Background: Postoperative pain management in gynecological surgery remains a significant challenge, with many patients experiencing moderate to severe pain despite standard analgesic interventions. The risk of complications, such as bleeding and prolonged recovery, is heightened by the use of certain analgesics, emphasizing the need for optimal pain management strategies. This study compares the efficacy of two multimodal analgesic regimens-ibuprofen-paracetamol and ketorolac-paracetamol-on pain, coagulation, and interleukin-6 (IL-6) levels. 



Methods: A double-blind randomized trial was conducted with 40 patients undergoing gynecological surgery. Group 1 received IV ibuprofen (400 mg) + paracetamol (1000 mg); Group 2 received IV ketorolac (30 mg) + paracetamol (1000 mg). Numeric Rating Scale (NRS), clotting time (CT), bleeding time (BT), and IL-6 were assessed at 6, 24, and 48 hours postoperatively. 



Results: Pain scores and CT did not differ significantly between the groups. The ketorolac group showed a significant increase in BT at 24 and 48 hours (p < 0.05), while the ibuprofen group had significantly lower IL-6 levels at 24 hours (p < 0.05). 



Conclusion: Both regimens were equally effective for pain control. However, ketorolac-paracetamol significantly prolonged bleeding time, while ibuprofen-paracetamol was more effective in reducing inflammation by lowering IL-6 levels. These differences should be considered, particularly in patients at risk of bleeding.

Keywords: pain management, coagulation profile, interleukin-6, ibuprofen, ketorolac, paracetamol, gynecological surgery

Received: July 6, 2025; Revised: September 22, 2025; Accepted: September 24, 2025; Prepublished online: November 21, 2025; Published: December 10, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maarif MK, Musba AMT, Datu MD, Gaus S, Wirawan NS, Adil A. Comparison of ibuprofen and paracetamol combination with ketorolac and paracetamol in patients undergoing gynecologic surgery:  A review of pain level, coagulation profile, and interleukin-6 levels. Anest. intenziv. Med. 2025;36(4):247-252. doi: 10.36290/aim.2025.043.
Download citation

References

  1. Erekson EA, Yip SO, Ciarleglio MM, Fried TR. Postoperative complications after gynecologic surgery. Obstetrics and Gynecology. 2011;118(4):785-93. doi: 10.1097/AOG.0b013e31822dac5d. Go to original source... Go to PubMed...
  2. Wick EC, Grant MC, Wu CL. Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques a review. JAMA Surg. 2017;152(7):691-7. doi: 10.1001/jamasurg.2017.0898. Go to original source... Go to PubMed...
  3. Supermaniam S. Laparoscopic Surgery in Gynaecology. In: Laparoscopic Surgery in Gynaecology and Common Diseases in Women. 1st ed. Melaka, Malaysia: Adequate Wonder; 2016.
  4. Horn R, Hendrix JM, Kramer J. Postoperative Pain Control. In: StatPearls. StatPearls Publishing.; 2025.
  5. Singh P, Rastogi S, Bansal M, Kumar S, Singh R, Nishad SG, et al. A Prospective Study to Assess the Levels of Interleukin-6 Following Administration of Diclofenac, Ketorolac and Tramadol After Surgical Removal of Lower Third Molars. J Maxillofac Oral Surg. 2015;14(2):219-25. doi: 10.1007/s12663-013-0609-1. Go to original source... Go to PubMed...
  6. Sun F, Zhang Y, Li Q. Therapeutic mechanisms of ibuprofen, prednisone and betamethasone in osteoarthritis. Mol Med Rep. 2017;15(2):981-7. doi: 10.3892/mmr.2016.6068. Go to original source... Go to PubMed...
  7. Mahmoodi AN, Patel P, Kim PY. Ketorolac. In: StatPearls. StatPearls Publishing; 2025.
  8. Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes IB, et al. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Ann Rheum Dis. 2023;82(6):773-87. doi: 10.1136/ard-2022-222784. Go to original source... Go to PubMed...
  9. Rose-John S. Local and systemic effects of interleukin-6 (IL-6) in inflammation and cancer. FEBS Lett. 2022;596(5):557-66. doi: 10.1002/1873-3468.14220. Go to original source... Go to PubMed...
  10. Wittes J. Sample Size Calculations for Randomized Controlled Trials. Epidemiol Rev. 2002;24(1):39-53. doi: 10.1093/epirev/24.1.39. Go to original source... Go to PubMed...
  11. Rahim MuhR, Musba AMT, Palinrungi AS, Ahmad MuhR, Muhadi R, Rum M. Perbandingan Antara Kombinasi Ibuprofen dan Parasetamol dengan Ketorolak dan Parasetamol Intravena Terhadap Derajat Nyeri dan Rasio Neutrofil Limfosit Pasca-Functional Endoscopic Sinus Surgery. Jurnal Anestesi Perioperatif. 2024;12(3):161-8. doi: 10.15851/jap.v12n3.3889. Go to original source...
  12. Fithri D, Wijaya D, Arifin H. Perbedaan Nilai Agregasi Trombosit Akibat Pengaruh Penggunaan Analgesia Ketorolak dan Ibuprofen Intravena Pascaoperasi di RSUP Haji Adam Malik Medan. Jurnal Anestesi Perioperatif. 2017;5(3):141-6. doi: 10.1581/jap.v5n3.1166. Go to original source...
  13. Douraiswami B, Dilip PK, Harish BN, Jagdish M. C-reactive protein and interleukin-6 levels in the early detection of infection after open fractures. J Orthop Surg (Hong Kong). 2012;20(3):381-5. doi: 10.1177/230949901202000325. Go to original source... Go to PubMed...
  14. Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 2000;31 Suppl 5:S202-10. doi: 10.1086/317520. Go to original source... Go to PubMed...
  15. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen. Ann Intern Med. 2005;142(7):506-9. doi: 10.7326/0003-4819-142-7-200504050-00009. Go to original source... Go to PubMed...
  16. Martini WZ, Deguzman R, Rodriguez CM, Guerra J, Martini AK, Pusateri AE, et al. Effect of Ibuprofen dose on platelet aggregation and coagulation in blood samples from pigs. Mil Med. 2015;180(3 Suppl):80-5. doi: 10.7205/MILMED-D-14-00395. Go to original source... Go to PubMed...
  17. Park A, Anderson D, Battaglino RA, Nguyen N, Morse LR. Ibuprofen use is associated with reduced C-reactive protein and interleukin-6 levels in chronic spinal cord injury. J Spinal Cord Med. 2022;45(1):117-25. Available from: https://www.tandfonline.com/doi/full/10.1080/10790268.2020.1773029. Go to original source...
  18. Younus LA. The potential impact of Ibuprofen on level of IL-6. Maaen Journal for Medical Sciences. 2024;3(1). doi: 10.55810/2789-9136.1038. Go to original source...
  19. Sun F, Zhang Y, Li Q. Therapeutic mechanisms of ibuprofen, prednisone and betamethasone in osteoarthritis. Mol Med Rep. 2017 Mar;15(2):981-7. Go to original source...
  20. Singh P, Rastogi S, Bansal M, Kumar S, Singh R, Nishad SG, et al. A Prospective Study to Assess the Levels of Interleukin-6 Following Administration of Diclofenac, Ketorolac and Tramadol After Surgical Removal of Lower Third Molars. J Maxillofac Oral Surg. 2015 Jun 1;14(2):219-25. Go to original source...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.